In the central nervous system, serotonin, an important neurotransmitter and trophic factor, is synthesized by both mast cells and neurons. Mast cells, like other immune cells, are born in the bone marrow and migrate to many tissues. We show that they are resident in the mouse brain throughout development and adulthood. Measurements based on capillary electrophoresis with native fluorescence detection indicate that a significant contribution of serotonin to the hippocampal milieu is associated with mast cell activation. Compared with their littermates, mast cell-deficient C57BL/6 KitW-sh/W-sh mice have profound deficits in hippocampus-dependent spatial learning and memory and in hippocampal neurogenesis. These deficits are associated with a reduction in cell proliferation and in immature neurons in the dentate gyrus, but not in the subventricular zone a neurogenic niche lacking mast cells. Chronic treatment with fluoxetine, a selective serotonin reuptake inhibitor, reverses the deficit in hippocampal neurogenesis in mast cell-deficient mice. In summary, the present study demonstrates that mast cells are a source of serotonin, that mast cell-deficient C57BL/6 KitW-sh/W-sh mice have disrupted hippocampus-dependent behavior and neurogenesis, and that elevating serotonin in these mice, by treatment with fluoxetine, reverses these deficits. We conclude that mast cells contribute to behavioral and physiological functions of the hippocampus and note that they play a physiological role in neuroimmune interactions, even in the absence of inflammatory responses.
Serotonin of mast cell origin contributes to hippocampal function
Creators
Katherine M. Nautiyal - Columbia University
Christopher A. Dailey - University of Illinois Urbana-Champaign
Jaquelyn L. Jahn - Barnard College
Elizabeth Rodriquez - Columbia University
Nguyen Hong Son - University of Illinois Urbana-Champaign
Jonathan V. Sweedler - University of Illinois Urbana-Champaign
Rae Silver - Columbia University Irving Medical Center
Publication Details
The European journal of neuroscience, v 36(3), pp 2347-2359
Publisher
Wiley
Number of pages
13
Grant note
P30DA018310 / NATIONAL INSTITUTE ON DRUG ABUSE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); European Commission
IOS 05-54514; DBI 320988 / NSF; National Science Foundation (NSF)
F31MH084384 / NATIONAL INSTITUTE OF MENTAL HEALTH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)
R01DE018866 / NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)
Resource Type
Journal article
Language
English
Academic Unit
Epidemiology and Biostatistics
Web of Science ID
WOS:000307167400010
Scopus ID
2-s2.0-84864824179
Other Identifier
991021448029104721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: